Midbrain organoids exhibit diverse cell types mirroring the midbrain’s intricate structure, including dopaminergic neurons.
These three-dimensional structures enable the modeling of neurodegenerative diseases, offer insights into developmental processes, and serve as a platform for drug testing, advancing our understanding of midbrain functionality.